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Abstract 
Background & Aims: Bariatric surgery might reduce overall mortality from obesity. We 
investigated whether survival times of patients who have undergone bariatric surgery are 
similar to those of the general population levels and are longer than in obese individuals who 
did not receive surgery. 
 
Methods: We performed a population-based cohort study of persons with a diagnosis of 
obesity listed in nationwide registries from Nordic countries, from 1980 through 2012. 
Bariatric surgery was analyzed in relation to all-cause mortality and the obesity-related 
morbidities cardiovascular disease, diabetes, cancer, and suicide. Poisson models provided 
standardized mortality ratios (SMRs) with 95% CIs. Multivariable Cox regression provided 
hazard ratios (HRs) for mortality in operated and non-operated participants. 
 
Results: Among 505,258 participants, 49,977 underwent bariatric surgery. Overall all-cause 
SMR was increased after surgery (1.94; 95% CI, 1.83–2.05) and increased with longer follow 
up, to 2.28 (95% CI, 2.07–2.51) ≥15 years post-surgery. SMRs were increased for 
cardiovascular disease (2.39; 95% CI, 2.17–2.63), diabetes (3.67; 95% CI, 2.85–4.72), and 
suicide (2.39; 95% CI, 1.96–2.92), but not for cancer (1.05; 95% CI, 0.95–1.17); SMRs 
increased with time. In non-operated obese participants, all-cause SMR was 2.15 (95% CI, 
2.11–2.20), which remained stable during follow up. Compared to non-operated obese 
participants, patients who underwent bariatric surgery had decreased overall mortality from 
all causes (HR, 0.63; 95% CI, 0.60–0.66), cardiovascular disease (HR, 0.57; 95% CI, 0.52–
0.63), and diabetes (HR, 0.38; 95% CI, 0.29–0.49), but increased mortality from suicide (HR, 
1.68; 95% CI, 1.32–2.14). Cancer mortality was decreased overall (HR, 0.84; 95% CI, 0.76–
0.93), but increased ≥15 years of follow up (HR, 1.20; 95% CI, 1.02–1.42). 
 
Conclusions: In a study of persons with a diagnosis of obesity listed in nationwide registries 
of Nordic countries, we found that obese patients who undergo bariatric surgery have longer 
survival times than non-operated obese individuals, but their mortality is higher than that of 
the general population and increases with time. Obesity-related morbidities could account for 
these findings. 
 
KEY WORDS:  gastric bypass, metabolic syndrome, outcome, NordOSCO 
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Introduction 
The prevalence of obesity is high globally, with over 600 million obese adults (body mass 
index [BMI] ≥30 kg/m2) in 2015, and is increasing.1 Cardiovascular disease, diabetes, and 
cancer are common obesity-related morbidities, and also common causes of death.1 Treatment 
of moderate obesity may include lifestyle intervention and medication, while obesity surgery 
is considered the most effective treatment of severe obesity (BMI ≥40 kg/m2).2 Compared to 
non-surgical weight loss treatment, obesity surgery can achieve a more pronounced and long-
lasting weight reduction, resulting in less comorbidity and better overall survival at least 
during the initial years after surgery.3-11 An exception is a reported increased risk of suicide 
following obesity surgery.9, 12 Importantly, whether the survival after obesity surgery 
approaches to that of the general population and whether the survival remains better than that 
of non-operated individuals with obesity in the long term (>10 years) is uncertain. Thus, the 
present study aimed to test two main hypotheses: (1) The long-term survival of the severely 
obese individuals undergoing obesity surgery starts moving towards, but not equaling, that of 
the general population, and (2) obesity surgery results in a better long-term survival than in 
non-operated individuals with obesity. If evidence supporting these hypotheses are observed 
they might be due to reductions in mortality from obesity-related morbidities. The hypotheses 
were tested in a cohort study in all Nordic countries with long and complete follow-up.  
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Methods 
Study design 
This population-based cohort study followed a detailed pre-defined study protocol and 
examined how obesity surgery influences all-cause mortality and disease-specific mortality 
during the 33-year study period 1980 through 2012. The cohort, entitled the Nordic Obesity 
Surgery Cohort (NordOSCO), incorporated data from nationwide health data registers from 
all five Nordic countries, i.e. Denmark, Finland, Iceland, Norway, and Sweden, and has been 
described in a cohort profile publication.13 The time required for all approvals and to collect, 
check, re-collect, and merge all data was 5½ years. The Nordic countries have similar and 
complete recording of hospital admissions and long and complete follow-up of death in all 
residents.14 Reporting of patient admissions, diagnosis codes, and surgical procedures to the 
national health data registries is mandatory by law, and is linked to the remuneration of all 
Nordic hospitals.14 Each Nordic resident is assigned a unique, personal identity code upon 
birth or immigration, which is used by governmental agencies, healthcare, and nationwide 
registries storing personal information for governmental and research purposes.14 This 
personal identity code system enables accurate linkage of information between registries for 
each individual.15, 16 The study was approved by all relevant ethical committees and data 
inspectorates in each of the participating countries.13 
 
Obesity cohort 
NordOSCo included all individuals with an obesity diagnosis recorded in any of the Nordic 
patient registries.13 These registries hold nationwide information on in-hospital care and out-
patient specialist care, including diagnoses and surgical procedures, with high concordance to 
the diagnoses and procedures recorded in the patient records.17-19 The dates of recording of 
obesity diagnosis and obesity surgery in the registries varied between the countries, namely 
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from 1996 to 2011 in Denmark, 1996 to 2012 in Finland, 1999 to 2012 in Iceland, 2007 to 
2011 in Norway, and 1980 to 2012 in Sweden. Follow-up started on the first date of a 
recorded obesity diagnosis, but only within the study period in each country, and lasted until 
death, emigration (outside the Nordic countries), or the end of study period, whichever 
occurred first. Emigration dates were retrieved from complete national population registries.13  
 
Exposure  
The exposure was obesity surgery and participants with obesity who did not undergo obesity 
surgery were defined as unexposed. Obesity surgery included open or laparoscopic approach 
of any of the following five techniques: gastric bypass, vertical banded gastroplasty, gastric 
banding, other restrictive procedures, or blocking procedures, as determined by the specific 
surgical codes in the patient registries. Participants entered the study at the time of obesity 
diagnosis after the country-specific entry period. Participants contributed observations to the 
non-operated group from the date of obesity diagnosis until date of surgery, date of death, end 
of study period, or emigration, whichever came first. Participants contributed to the operated 
group from the date of obesity surgery until date of death, end of study period, or emigration. 
For participants who underwent obesity surgery, follow-up changed from the non-operated 
group (obesity diagnosis) to the operated group on the date of surgery. If the obesity diagnosis 
was recorded during the hospitalization of the obesity surgery, the follow-up started from the 
date of surgery. The registration of obesity surgery in the patient registries is 97% concordant 
with operation charts.20  
 
Outcomes  
The main outcome was all-cause mortality. Secondary outcomes were mortality specifically 
in the obesity-related morbidities cardiovascular disease, diabetes, cancer, and suicide. Dates 
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and causes of death were obtained from the national death registries up until December 31, 
2012. Death due to diabetes included deaths caused by any type of diabetes (although the vast 
majority was due to diabetes type 2). The completeness for all-cause mortality data in these 
registers is 100%, and at least 96% for causes of death.21-23 In Finland, all death certificates 
are checked by forensic physicians, and completed with the physician or pathologist writing 
the death certificate when needed.23 The data quality in the Norwegian cause of death registry 
has been rated in the best category in an external review.22 In Sweden, the concordance 
between cause of death registry and the medical records data is very high, 98% in the age 
group <45 years and 91% for the age group 45-64 years.21 The validity of deaths from suicide 
in the cause of death registries is high; a re-review of death certificates due to suspected 
suicide, unintentional and unclear deaths did not increase the overall number of suicides 
compared to registries in Denmark, Norway and Sweden.24 In Finland, >90% of all persons 
who have died due to unclear reason, unintentional causes, or injury, and >99% of persons 
who died from suspected suicide undergo medico-legal or medical autopsy, after which the 
cause of death is recorded in the cause of death registry.25 
 
Statistical analysis 
First, the all-cause mortality in the obesity surgery cohort was compared with its 
corresponding background population and the non-operated obese cohort with its 
corresponding background population. The corresponding background population of each of 
these cohorts had the same distribution of age (5-year age group), sex, and country as the 
participants in the specific cohort. Standardized mortality ratios (SMRs) with 95% confidence 
intervals (CIs) were calculated. The SMRs were computed using a Poisson regression with 
outcome observed number of deaths in the study cohorts by age, sex, calendar year, and 
exposure status and offset variable expected deaths in the population by age, sex and calendar 
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year. Confidence intervals were computed using a sandwich estimator of the variance. For the 
analyses, data were collapsed by age, sex, calendar year, and four categories of follow-up 
time to reduce bias of the standard error as data from the reference population was available 
as grouped data.  
The expected numbers of death were derived from country-specific mortality rates 
categorized by sex, age (5-year categories), and calendar year (5-year categories), retrieved 
from the Nordic cause of death registries. Obesity surgery was treated as a time-dependent 
covariate. In stratified analyses, participants were grouped into follow-up periods after date of 
surgery or date of obesity diagnosis into 0-4 years, 5-9 years, 10-14 years, and ≥15 years. The 
five obesity surgery techniques were also analyzed separately. 
 
Second, to estimate all-cause and disease-specific mortality comparing operated and non-
operated participants with obesity, multivariable Cox regression with adjustment for potential 
confounders was used. The calculated hazard ratios (HR) with 95% CI were adjusted for age 
(continuous), sex (male or female), calendar year (continuous), country (Denmark, Finland, 
Iceland, Norway, or Sweden), and comorbidity (Charlson Comorbidity Index 0, 1, 2, or ≥3). 
Comorbidity was assessed using the most recent and well-validated Charlson Comorbidity 
Index,26 which was based on diagnoses in the patient registries up to one year before the entry 
date into the cohort. This restriction in time was made to allow all relevant comorbidities to 
be included, but to avoid including comorbidities or complications due to obesity surgery. 
Sub-analyses were stratified by age groups (<30, 30-39, 40-49, or ≥50 years), sex (female or 
male), and follow-up periods (0-4 years, 5-9 years, 10-14 years, and ≥15 years). The 
proportionality assumption was verified using Schoenfeld residuals. There were no missing 
data. 
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All data management and statistical analyses were conducted by a senior biostatistician 
(G.S.), using Stata/MP version 15.1 (StataCorp LLC, College Station, TX, USA). 
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Results 
Patients (Table 1) 
Of all 505,258 cohort participants with obesity, 49,977 (9.9%) underwent obesity surgery 
(312,128 person-years of follow-up) and 494,842 did not (3,188,969 person-years, including 
years prior to any obesity surgery). In the obesity surgery group, the median age was lower 
and the frequency of women was higher than in the non-operated group. Sweden contributed 
most participants in the obesity surgery group (72.1%) and Denmark contributed most 
participants in the non-operated group (41.3%). In the surgery group, the most common 
obesity surgical technique was gastric bypass (73.4%).  
 
Mortality in operated individuals with obesity compared to population levels (Table 2) 
The overall (entire study period) SMR of all-cause mortality after obesity surgery was 1.94 
(95% CI 1.83-2.05). The SMRs of all-cause mortality increased with follow-up periods from 
1.62 (95% CI 1.48-1.79) 0-4 years after surgery to 2.28 (95% CI 2.07-2.51) ≥15 years after 
surgery (Figure 1). Different obesity surgical techniques yielded similar SMRs 
(Supplementary Table 1). For cardiovascular disease, the overall SMR was 2.39 (95% CI 
2.17-2.63) and the SMR increased from 1.84 (95% CI 1.54-2.20) 0-4 years after surgery to 
2.71 (95% CI 2.30-3.18) ≥15 years after surgery. For diabetes, the overall SMR was 3.67 
(95% CI 2.85-4.72), with increasing SMRs from 1.26 (95% CI 0.60-2.64) 0-4 years after 
surgery to 6.26 (95% CI 4.54-8.64) ≥15 years after surgery. For cancer, the overall SMR was 
not increased (SMR 1.05, 95% CI 0.95-1.17), but an increase was observed ≥15 years after 
surgery (1.46, 95% CI 1.28-1.67). For suicide, the overall SMR was 2.39 (95% CI 1.96-2.92), 
and the SMR increased from 1.93 (95% CI 1.43-2.61) 0-4 years after surgery to 3.39 (2.11-
5.44) ≥15 years after surgery.  
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Mortality in non-operated individuals with obesity compared to population levels (Table 2) 
In obese participants who did not undergo obesity surgery, the overall all-cause SMR was 
2.15 (95% CI 2.11-2.20), with SMRs remaining stable during follow-up (Figure 1). The 
disease-specific overall SMRs were 2.26 (95% CI 2.15-2.37) for cardiovascular disease, 6.89 
(95% CI 6.54-7.27) for diabetes, 1.25 (95% CI 1.23-1.28) for cancer, and 1.15 (95% CI 1.06-
1.26) for suicide, all with stable SMRs during follow-up.  
 
Mortality in operated compared to non-operated participants with obesity (Table 3) 
Participants who had undergone obesity surgery had a lower HRs of overall all-cause 
mortality compared to non-operated participants with obesity (adjusted HR 0.63, 95% CI 
0.60-0.66). The HRs remained decreased for all follow-up periods after surgery, and the HR 
was 0.74 (95% CI 0.68-0.81) after ≥15 years of follow-up. The HRs decreased with age from 
1.03 (95% CI 0.83-1.27) among participants younger than 30 years to 0.54 (95% CI 0.50-
0.58) in individuals ≥50 years. The HRs were similar between the sexes as well as for the 
different obesity surgical techniques (Supplementary Table 2). Compared to the non-operated 
group, the operated group had decreased HRs of overall mortality from cardiovascular disease 
(HR 0.57, 95% CI 0.52-0.63) and diabetes (HR 0.38, 95% CI 0.29-0.49), and the HRs 
remained decreased over follow-up periods (Table 3). For cancer, the overall mortality was 
decreased (HR 0.84, 95% CI 0.76-0.93), but the HRs increased over follow-up periods, and 
the HR was increased after ≥15 years of follow-up (HR 1.20, 95% CI 1.02-1.42). The overall 
HR of mortality from suicide was increased (HR 1.68, 95% CI 1.32-2.14), and this increase 
remained over follow-up periods. For all mortality outcomes, the point estimates were higher 
in the latest (≥15 years) compared to the initial (0-4 years) follow-up period.       
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Discussion 
This study indicates that individuals who undergo obesity surgery remain at a higher all-cause 
mortality compared to the background population, with increasing SMRs over time after 
surgery. The overall SMRs were increased for cardiovascular disease, diabetes, and suicide, 
but not for cancer, and all disease-specific SMRs increased with longer follow-up after 
surgery. Compared to non-operated participants with obesity, the operated patients had 
overall decreased mortality from all causes, cardiovascular disease, diabetes, and cancer 
(except for increased cancer mortality in the ≥15 years follow-up period), whereas mortality 
due to suicide was increased, and the HRs for all outcomes were higher in the last follow-up 
period compared to the first. 
 
Strengths of the study include the population-based design, availability of a corresponding 
background population for comparison, large sample size, and the long and complete follow-
up. The high quality of the registry data in the Nordic countries has been verified in multiple 
studies, but some limited non-differential misclassification might still exist. This might make 
the observed associations appear smaller than they are. The Nordic populations share 
sociodemographic characteristics, genetic background, cultural traditions, and norms, and 
have similar and publicly funded healthcare-, social- and registration systems, as well as 
mortality rates. Furthermore, the guidelines for BMI and comorbidity requirements for 
bariatric surgery are similar in these countries.27, 28 Therefore, combining data from these 
countries does not introduce much heterogeneity, but improves statistical power and 
facilitates generalisability.14 Patients selected for obesity surgery may be healthier than non-
operated patients with obesity and in short follow-up even less likely to die than the 
background population. Yet, their severe obesity and associated comorbidities together with a 
risk of postoperative mortality act against such selection bias. A limitation is the lack of data 
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on some potential confounders not adjusted for, mainly BMI, socioeconomic status, tobacco 
smoking, and alcohol use. However, weight change lies in the proposed causal pathway 
between obesity surgery and survival and is therefore not a confounder. Moreover, individuals 
selected for obesity surgery constitute a relatively homogenous group regarding BMI and 
comorbidity.27 The lack of BMI in the non-operated patients with obesity could be seen as a 
major limitation, but this only affects the comparison between the operated and non-operated 
patients with obesity, not the analysis of SMRs. Moreover, the results on the comparisons 
between operated and non-operated individuals with obesity are in line with previous studies 
on the topic.8-10 One might argue that the lack of adjustment for socioeconomic status might 
affect the access to surgery. However, in all the Nordic countries, healthcare, including 
bariatric procedures, are covered by the national social insurance, and therefore 
socioeconomic status is not associated to access to treatment (i.e. the exposure) and should 
not be a confounder. Smoking and alcohol use are indirectly reflected in the Charlson 
comorbidity score. As the risk of chronic obstructive pulmonary disease (COPD) is linearly 
associated with smoked pack-years and cigarettes per day,29 and the prevalence of smokers is 
much higher in a population with COPD compared to those not having COPD,30 the 
adjustment for comorbidity is likely to catch the most heavy smokers. Similarly, alcohol 
consumption is strongly associated with liver disease,31 and the adjustment for comorbidity 
therefore reduces the confounding by heavy alcohol use. These were adjusted for in the Cox 
regression analysis without changing the risk estimates, indicating no or limited confounding 
by these factors. Because the reporting of surgical procedures to the national patient registries 
is mandatory and the hospital reimbursement depends on this reporting, the assessment of 
obesity surgery should be complete. A limitation, however, is that obesity diagnosis in non-
operated participants with obesity is likely under-reported in the registries, and those who are 
diagnosed might be a selected group of older patients with more comorbidities. However, the 
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adjustment for age, comorbidity and other potential confounders in the Cox regression 
analyses should counteract biased risk estimates. The lack of adjustment for psychiatric 
conditions can be seen as a limitation regarding the analysis of suicide. However, psychiatric 
conditions are more likely to be in the causal pathway leading to suicide rather than confound 
the association, and should therefore not be adjusted for. Also, there is no validated 
psychiatric comorbidity scale that can be used in the analyses. 
  
It has been unclear whether the survival after obesity surgery approaches that of the 
corresponding background population. A Swedish study comparing 13,273 individuals who 
had undergone obesity surgery (some of whom are also included in the present study) with 
age- and sex-matched population controls suggested a slightly increased all-cause mortality 
after obesity surgery,32 but changes over time after surgery and cause-specific mortality were 
not assessed. A population-based cohort study from the United States found increased age- 
and sex-specific mortality rates in obesity surgery patients (n=16,683) compared to the 
general population, and cardiovascular death specifically,12 but the follow-up was limited 
(only 20% were followed up for 5 years), and other disease-specific causes of death were not 
examined. The present study, with a much larger sample size and longer follow-up than 
previous studies, shows increased mortality after obesity surgery compared to the background 
population, and interestingly, the mortality increased over time compared to the population 
levels. A possible explanation for the overall increased mortality rates is that obesity surgery 
rarely leads to normalized weight, but the average weight remains higher than that of the 
population.33, 34 This is supported by the relatively stable SMRs in the non-operated group 
over time, who are likely to have stable or slowly increasing body weight. A Swedish study 
showed that patients undergoing obesity surgery had lost a mean of over 30kg of their weight 
at 1 year of follow-up, and that the weight remained 20kg lower compared to the baseline in 
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the long-term.34 A possible reason for the increasing mortality rates over time after surgery is 
weight gain; up to 50% of obesity surgery patients regain weight within two years of 
surgery,35 and new comorbidities that increase the risk of cardiovascular and diabetic deaths 
may develop over time.33 However, those that manage to lose weight and maintain the weight 
loss seem to have a long-lasting resolution of comorbidity.33 In a study from the United 
States, achieving BMI under 30 one year postoperatively was associated to resolution of 
comorbidities.36 Compared to the background population, excess mortality among the obesity 
surgery group was found specifically in cardiovascular disease, diabetes, and suicide. 
However, the cancer mortality returned to that of the population level for up to 15 years after 
obesity surgery, after which it was increased. This late increase in cancer mortality might be 
due to the longer latency interval between weight change and cancer development compared 
to cardiovascular diseases and diabetes. However, this increase in cancer mortality might be 
due to lower mortality from competing causes, such as lower cardiovascular mortality in the 
obesity surgery group. As more than 5000 patients representing three main types of surgery, 
namely gastric bypass, gastric banding and vertical banded gastroplasty, were included, the 
study should be generalizable to all patients undergoing these types of surgeries. Furthermore, 
the risk of mortality after different types of surgery were similar, with the exception of having 
a slightly higher risk after blocking procedures. As there are major differences in weight loss 
outcomes between these surgery types according to a meta-analysis,37 the similar mortality 
rates between the surgery types in this study do not support the hypothesis that weight loss 
alone mediates mortality outcomes after obesity surgery. Taken together, the mortality of the 
patients undergoing obesity surgery does not approach that of the country-, age- and sex-
adjusted general population, but the differences instead increase over time. 
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In line with the present study, previous larger studies comparing mortality in obesity surgery 
patients with non-operated patients with obesity have shown decreased all-cause mortality 
following obesity surgery, but these earlier studies have had shorter follow-up.8-11 
Interestingly, the current study found that the reduction in mortality remained over time, 
although the HRs were higher with longer follow-up periods. A decreasing mortality was 
found with increasing age, and no survival advantage was found in patients <30 years at 
obesity surgery; an observation supported by a study from the United States comparing 7,925 
patients undergoing obesity surgery with an equal number of matched controls with obesity.38 
Obesity-related morbidities might take time to develop, and therefore the influence of obesity 
surgery might not be seen in younger patients.39 Compared to non-operated participants with 
obesity of the present study, the obesity surgery patients had decreased mortality from 
obesity-related diseases, i.e. cardiovascular diseases, diabetes, and cancer, except for the 
increased risk of cancer mortality seen after ≥15 years of follow-up. Reductions in the 
occurrence of diabetes40 and cardiovascular events, 41 after obesity surgery have been 
identified in earlier studies. A study indicated that recovery from diabetes following obesity 
surgery may be reduced from 72% at 2 years, to 30% at 10 years after surgery.34 At 10 years 
after obesity surgery, newly diagnosed diabetes (7%), hypertension (41%), and 
hypertriglyceridemia (17%) often occur in patients without these comorbidities before 
surgery.42 Taken together, the present study confirms the findings of previous studies that 
obesity surgery decreases mortality compared to controls with obesity, and additionally 
suggests that this decrease is long-lasting, also after 15 years of follow-up.  
 
The mortality from suicide was substantially increased after obesity surgery compared to both 
the background population and non-operated participants with obesity, and the risk estimates 
tended to increase over time after surgery. Suggested mechanisms behind this phenomenon 
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include changes that might occur after obesity surgery, i.e. unexpected recurrence of medical 
comorbidities,43 surgical complications,44 impulsiveness related to increased sensitivity to 
alcohol,45, 46 decreased absorption of medications such as antidepressants,47 psychosocial 
factors including persistent depression symptoms,48 and decreased emotional well-being 
related to unforeseen weight gain.43 A previous study in Sweden found that suicide risk was 
increased in bariatric surgery patients, even after adjustment for previous psychiatric care and 
medication use, and that those that committed suicide had similar or even greater weight loss 
than those who did not commit suicide.49 The increased suicide rates after obesity surgery 
seen in the present study are in line with some previous studies,12, 38 but an important finding 
of this study is that the suicide rate increased over time to more than 3-fold that of the general 
population after ≥15 years of surgery.  
 
In conclusion, this all-Nordic population-based cohort study indicates that obesity surgery 
patients have lower mortality rates than non-operated patients with obesity, but higher 
mortality than the corresponding background population, a difference that increases over time 
after surgery. These findings may at least partly be explained by mortality from 
cardiovascular disease, diabetes, cancer, and suicide.   
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Figure legends 
 
Figure 1. The standardized mortality ratios (SMR) over time for obese patients undergoing 
surgery and not undergoing surgery. 
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Table 1. Characteristics of all 505,258 participants with obesity in a Nordic cohort 
 No obesity surgery 
n=494,842 
Number (%) 
Obesity surgery 
n=49,977 
Number (%) 
Person-years of follow-up 3,188,969 (100.0) 312,128 (100.0) 
Age at entry, years   
<30 98,249 (19.8) 7,815 (15.6) 
30-39 95,887 (19.4) 14,388 (28.8) 
40-49 84,560 (17.1) 15,922 (31.9) 
≥50 216,146 (43.7) 11,852 (23.7) 
Sex   
Male 160,435 (32.4) 12,730 (25.5) 
Female 334,407 (67.6) 37,247 (74.5) 
Country   
Denmark 204,263 (41.3) 3,269 (6.5) 
Finland 87,450 (17.7) 4,429 (8.9) 
Iceland 15,213 (3.1) 731 (1.5) 
Norway 33,866 (6.8) 5,507 (11.0) 
Sweden 154,050 (31.1) 36,041 (72.1) 
Calendar year at entry   
<1990 21,004 (4.2) 2,334 (4.7) 
1990-1999 85,280 (17.2) 6,751 (13.5) 
2000-2004 76,611 (15.5) 3,172 (6.4) 
2005-2009 190,763 (38.6) 15,553 (31.1) 
≥2010 121,184 (24.5) 22,167 (44.4) 
Follow-up time, years   
≤4 259,929 (52.5) 24,563 (49.1) 
5-9 133,544 (27.0) 10,818 (21.6) 
≥10 101,369 (20.5) 14,596 (29.2) 
Charlson Comorbidity Index   
0 415,494 (84.0) 46,648 (93.3) 
1 71,119 (14.4) 3,122 (6.3) 
2 7,234 (1.5) 191 (0.4) 
≥3 995 (0.2) 16 (0.0) 
Obesity surgical technique    
Gastric bypass Not applicable 36,678 (73.4) 
Vertical banded gastroplasty Not applicable 5,487 (11.0) 
Gastric banding Not applicable 5,450 (10.9) 
Other restrictive procedures Not applicable 1,578 (3.2) 
Blocking procedures Not applicable 784 (1.5) 
Causes of mortality   
All-cause 75,345 (15.2) 1,784 (3.6) 
Cardiovascular diseases 30,740 (6.2) 525 (1.1) 
Diabetes 5,100 (1.0) 64 (0.1) 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Cancer 13,880 (2.8) 422 (0.8) 
Suicide 561 (0.1) 98 (0.2) 
 
Table 2. Standardized mortality ratios (SMRs) and 95% confidence intervals (CI) in 
participants with obesity who have undergone obesity surgery and not, compared with the 
background population 
 
 Non-operated with obesity Obesity surgery 
Cause of death 
stratified by 
follow-up period 
Observed / 
Expected* 
number of 
deaths 
SMR  
(95% CI) 
Observed / 
Expected* 
number of 
deaths 
SMR  
(95% CI) 
All causes 
Total 75,345 / 34,982 2.15 (2.11-2.20) 1,784 / 922 1.94 (1.83-2.05) 
0-4 years 35,021 / 16,204 2.16 (2.09-2.24) 508 / 313 1.62 (1.48-1.79) 
5-9 years 20,244 / 9,673 2.09 (2.01-2.18) 348 / 174 2.00 (1.75-2.29) 
10-14 years 12,052 / 5,500 2.19 (2.07-2.32) 328 / 172 1.91 (1.66-2.20) 
≥15 years 8,028 / 3,605 2.23 (2.10-2.36) 600 / 263 2.28 (2.07-2.51) 
Cardiovascular  
Total 30,740 / 13,613 2.26 (2.15-2.37) 525 / 220 2.39 (2.17-2.63) 
0-4 years 14,249 / 6,175 2.31 (2.15-2.48) 118 / 64 1.84 (1.54-2.20) 
5-9 years 8,377 / 3,778 2.22 (2.03-2.42) 108 / 41 2.66 (2.17-3.26) 
10-14 years 4,926 / 2,155 2.29 (2.03-2.58) 105 / 43 2.43 (1.90-3.09) 
≥15 years 3,188 / 1,504 2.12 (1.85-2.42) 194 / 72 2.71 (2.30-3.18) 
Diabetes  
Total 5,100 / 740 6.89 (6.54-7.27) 64 / 18 3.67 (2.85-4.72) 
0-4 years 2,067 / 335 6.17 (5.65-6.73) 7 / 6 1.26 (0.60-2.64) 
5-9 years 1,455 / 212 6.87 (6.27-7.53) 13 / 3 4.09 (2.46-6.79) 
10-14 years 952 / 116 8.21 (7.25-9.30) 10 / 3 3.04 (1.78-5.17) 
≥15 years 626 / 77 8.14 (6.91-9.60) 34 / 5 6.26 (4.54-8.64) 
Cancer  
Total 13,880 / 11,067 1.25 (1.23-1.28) 422 / 401 1.05 (0.95-1.17) 
0-4 years 6,876 / 5,259 1.31 (1.27-1.35) 82 / 132 0.62 (0.50-0.77) 
5-9 years 3,673 / 3,052 1.20 (1.15-1.26) 81 / 77 1.05 (0.85-1.31) 
10-14 years 2,089 / 1,708 1.22 (1.16-1.29) 92 / 77 1.19 (0.95-1.48) 
≥15 years 1,242 / 1,049 1.18 (1.08-1.29) 167 / 114 1.46 (1.28-1.67) 
Suicide  
Total 561 / 486 1.15 (1.06-1.26) 98 / 41 2.39 (1.96-2.92) 
0-4 years 344 / 274 1.26 (1.13-1.40) 41 / 21 1.93 (1.43-2.61) 
5-9 years 121 / 125 0.96 (0.81-1.16) 22 / 9 2.56 (1.69-3.87) 
10-14 years 59 / 57 1.03 (0.77-1.38) 17 / 6 2.92 (1.74-4.91) 
≥15 years 37 / 30 1.24 (0.91-1.70) 19 / 5 3.39 (2.11-5.44) 
*Sex-, age-, calendar year- and country-specific mortality rate rounded to nearest integer. 
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 No obesity surgery 
 
Obesity surgery 
Cause of death  Number of deaths / 
person-years* 
Number of 
deaths / person-
years 
HR 
(95% CI)†* 
All causes  
Follow-up           Total 75,345 / 3,188,969 1,784 / 312,128 0.63 (0.60-0.66) 
       0-4 years  35,021 / 1,821,156 508 / 163,387 0.60 (0.54-0.66) 
5-9 years 20,244 / 793,408 348 / 64,232 0.67 (0.59-0.75) 
10-14 years 12,052 / 363,009 328 / 43,372 0.65 (0.58-0.73) 
≥15 years 8,028 / 211,396 600 / 41,136 0.74 (0.68-0.81) 
Age             <30 years 921 / 613,667 132 / 60,943 1.03 (0.83-1.27) 
30-39 years 2,298 / 602,666 334 / 96,251 0.85 (0.74-0.97) 
40-49 years 6,401 / 584,928 601 / 94,852 0.65 (0.60-0.72) 
≥50 years 65,725 / 1,387,698 717 / 60,082 0.54 (0.50-0.58) 
Sex                        Male 31,120 / 1,021,086 656 / 71,429 0.65 (0.60-0.71) 
Female 44,225 / 2,167,883 1,128 / 240,699 0.62 (0.58-0.66) 
Cardiovascular  
Follow-up           Total 30,740 / 3,188,969 525 / 312,128 0.57 (0.52-0.63) 
0-4 years 14,249 / 1,821,156 118 / 163,387 0.43 (0.35-0.51) 
5-9 years 8,377 / 793,408 108 / 64,232 0.58 (0.48-0.70) 
10-14 years 4,926 / 363,009 105 / 43,372 0.55 (0.45-0.67) 
≥15 years 3,188 / 211,396 194 / 41,136 0.74 (0.64-0.85) 
Diabetes  
Follow-up           Total 5,100 / 3,188,969 64 / 312,128 0.38 (0.29-0.49) 
0-4 years 2,067 / 1,821,156 7 / 163,387 0.20 (0.10-0.42) 
5-9 years 1,455 / 793,408 13 / 64,232 0.42 (0.24-0.72) 
10-14 years 952 / 363,009 10 / 43,372 0.26 (0.14-0.48) 
≥15 years 626 / 211,396 34 / 41,136 0.53 (0.38-0.75) 
Cancer  
Follow-up        Total  13,880 / 3,188,969 422 / 312,128 0.84 (0.76-0.93) 
0-4 years 6,876 / 1,821,156 82 / 163,387 0.47 (0.38-0.59) 
5-9 years 3,673 / 793,408 81 / 64,232 0.86 (0.69-1.08) 
10-14 years 2,089 / 363,009 92 / 43,372 0.94 (0.76-1.16) 
≥15 years 1,242 / 211,396 167 / 41,136 1.20 (1.02-1.42) 
Suicide  
Follow-up        Total 561 / 3,188,969 98 / 312,128 1.68 (1.32-2.14) 
0-4 years 344 / 1,821,156 41 / 163,387 1.26 (0.89-1.77) 
5-9 years 121 / 793,408 22/ 64,232 2.19 (1.36-3.52) 
10-14 years 59 / 363,009 17 / 43,372 2.38 (1.36-4.18) 
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Table 
3. Hazard ratios (HRs) and 95% confidence intervals (CIs) of mortality comparing 
participants with obesity who have undergone obesity surgery with non-operated 
participants with obesity 
* Sex-, age-, calendar year- and country-specific mortality rate rounded to nearest integer. 
†Adjusted for age, sex, calendar year, country and comorbidity (excluding the variable analyzed)  
 
≥15 years 37 / 211,396 18 / 41,136 2.14 (1.20-3.82) 
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Supplementary Table 1. Risk of mortality after obesity surgery, stratified by surgical 
technique, compared to the corresponding background population patients  
 
Type of obesity surgery Observed / Expected* 
number of deaths 
Standardized mortality ratio 
(95% confidence interval) 
Gastric bypass 499 / 262 1.90 (1.74-2.08) 
Vertical banded gastroplasty 622 / 316 1.97 (1.82-2.13) 
Gastric banding 510 / 282 1.81 (1.66-1.97) 
Other restrictive procedures 59 / 27 2.16 (1.68-2.79) 
Blocking procedures 94 / 35 2.72 (2.22-3.33) 
 
*Sex-, age-, calendar year- and country-specific mortality rate. 
 
 
 
Supplementary Table 2. Risk of mortality comparing participants with obesity who have undergone 
obesity surgery with those who have not, stratified by obesity surgery technique 
 
Obesity surgery technique Number of deaths / 
person-years 
Hazard ratio 
 (95% confidence interval) * 
No obesity surgery 75,345 / 3,188,969 1.00 (Reference) 
Gastric bypass 499 / 126,592 0.66 (0.60-0.72) 
Vertical banded gastroplasty 622 / 87,766 0.62 (0.58-0.68) 
Gastric banding 510 / 77,813 0.57 (0.53-0.63) 
Other restrictive procedures 59 / 9,784 0.65 (0.51-0.84) 
Blocking procedures 94 / 10,172 0.84 (0.69-1.03) 
 
* Adjusted for age, sex, calendar year, country, and comorbidity  
 
 
